BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15131892)

  • 1. Two-color immunostaining of liver fine needle aspiration biopsies with CD34 and carcinoembryonic antigen. Potential utilization in the diagnosis of primary hepatocellular carcinoma vs. metastatic tumor.
    Yoder M; Zimmerman RL; Bibbo M
    Anal Quant Cytol Histol; 2004 Apr; 26(2):61-4. PubMed ID: 15131892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL
    Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the CD34 and CD10 immunostains using a two-color staining protocol in liver fine-needle aspiration biopsies.
    Zimmerman RL; Logani S; Baloch Z
    Diagn Cytopathol; 2005 Feb; 32(2):88-91. PubMed ID: 15637673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pCEA canalicular immunostaining in fine needle aspiration biopsy diagnosis of hepatocellular carcinoma.
    Wee A; Nilsson B
    Acta Cytol; 1997; 41(4):1147-55. PubMed ID: 9250313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal carcinoembryonic antigen staining in the cytologic differential diagnosis of primary and metastatic hepatic malignancies.
    Wolber RA; Greene CA; Dupuis BA
    Acta Cytol; 1991; 35(2):215-20. PubMed ID: 1709323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of polyclonal and monoclonal antibodies against carcinoembryonic antigen in hepatic fine-needle aspirates.
    Rishi M; Kovatich A; Ehya H
    Diagn Cytopathol; 1994 Dec; 11(4):358-61; discussion 361-2. PubMed ID: 7895575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
    Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
    Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
    Wang L; Vuolo M; Suhrland MJ; Schlesinger K
    Acta Cytol; 2006; 50(3):257-62. PubMed ID: 16780018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical localization of polyclonal carcinoembryonic antigen in hepatocellular carcinomas.
    Carrozza MJ; Calafati SA; Edmonds PR
    Acta Cytol; 1991; 35(2):221-4. PubMed ID: 1851357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of CD34 and factor VIII to diagnose hepatocellular carcinoma on fine needle aspirates.
    Gottschalk-Sabag S; Ron N; Glick T
    Acta Cytol; 1998; 42(3):691-6. PubMed ID: 9622689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
    de Boer WB; Segal A; Frost FA; Sterrett GF
    Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma.
    Christensen WN; Boitnott JK; Kuhajda FP
    Mod Pathol; 1989 Jan; 2(1):8-12. PubMed ID: 2466290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma versus carcinoma metastatic to the liver. Value of stains for carcinoembryonic antigen and naphthylamidase in fine needle aspiration biopsy material.
    Wong MA; Yazdi HM
    Acta Cytol; 1990; 34(2):192-6. PubMed ID: 2157322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
    Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A
    Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
    Ma CK; Zarbo RJ; Frierson HF; Lee MW
    Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma.
    Karabork A; Kaygusuz G; Ekinci C
    Pathol Res Pract; 2010 Aug; 206(8):572-7. PubMed ID: 20400233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F; Abdallah H; Meschter S
    Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
    Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical staining of fine-needle aspiration biopsies of the liver as a diagnostic tool for hepatocellular carcinoma.
    Johnson DE; Powers CN; Rupp G; Frable WJ
    Mod Pathol; 1992 Mar; 5(2):117-23. PubMed ID: 1374187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of CD10 immunohistochemical staining on cellblock in differentiating hepatocellular carcinoma from secondary malignancies of liver.
    Singha J; Khan K; Chatterjee S
    Indian J Pathol Microbiol; 2018; 61(4):510-515. PubMed ID: 30303139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.